Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-083749
Filing Date
2025-06-09
Accepted
2025-06-09 16:15:48
Documents
1
Period of Report
2025-06-05

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 7786
  Complete submission text file 0000950170-25-083749.txt   9286
Mailing Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 124 DVORA HANEVI'A ST. TEL AVIV L3 6944020
Business Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 124 DVORA HANEVI'A ST. TEL AVIV L3 6944020 972 (3) 914-8213
TEVA PHARMACEUTICAL INDUSTRIES LTD (Issuer) CIK: 0000818686 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 2150 WOODWARD STREET, SUITE 100 AUSTIN TX 78744
Business Address
Nisen Perry (Reporting) CIK: 0001683791 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-16174 | Film No.: 251034307